Drug re-purposing by targeting Dengue and CHIKV

One of our long standing dream to use drug re-purpose or repositioning strategy on neglected tropical diseases such as Dengue or CHIKV was finally successful with the publication of the latest article entitled “Reaching beyond HIV/HCV: nelfinavir as a potential starting point for broad-spectrum protease inhibitors against dengue and chikungunya virus” in RSC Advances (LINK). We are in process to further boost the selectivity index using computer aided drug design strategy.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s